Find Vinblastine Sulfate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

USP

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

6RELATED EXCIPIENT COMPANIES

7EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

API/FDF Prices: Book a Demo

API REF. PRICE (USD/KG)

GLOBAL SALES INFORMATION

Annual Reports

NA

MARKET PLACE

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 143-67-9, Velban, Velsar, Vinblastine (sulfate), Velbe, Exal
Molecular Formula
C46H60N4O13S
Molecular Weight
909.1  g/mol
InChI Key
KDQAABAKXDWYSZ-PNYVAJAMSA-N
FDA UNII
N00W22YO2B

Vinblastine Sulfate
Antitumor alkaloid isolated from Vinca rosea. (Merck, 11th ed.)
1 2D Structure

Vinblastine Sulfate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15R,17S)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate;sulfuric acid
2.1.2 InChI
InChI=1S/C46H58N4O9.H2O4S/c1-8-42(54)23-28-24-45(40(52)57-6,36-30(15-19-49(25-28)26-42)29-13-10-11-14-33(29)47-36)32-21-31-34(22-35(32)56-5)48(4)38-44(31)17-20-50-18-12-16-43(9-2,37(44)50)39(59-27(3)51)46(38,55)41(53)58-7;1-5(2,3)4/h10-14,16,21-22,28,37-39,47,54-55H,8-9,15,17-20,23-26H2,1-7H3;(H2,1,2,3,4)/t28-,37-,38+,39+,42-,43+,44+,45-,46-;/m0./s1
2.1.3 InChI Key
KDQAABAKXDWYSZ-PNYVAJAMSA-N
2.1.4 Canonical SMILES
CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O.OS(=O)(=O)O
2.1.5 Isomeric SMILES
CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O.OS(=O)(=O)O
2.2 Other Identifiers
2.2.1 UNII
N00W22YO2B
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Cellblastin

2. Lemblastine

3. Sulfate, Vinblastine

4. Velban

5. Velbe

6. Vinblastin Hexal

7. Vinblastina Lilly

8. Vinblastine

9. Vinblastinsulfat-gry

10. Vincaleukoblastine

2.3.2 Depositor-Supplied Synonyms

1. 143-67-9

2. Velban

3. Velsar

4. Vinblastine (sulfate)

5. Velbe

6. Exal

7. Vlb Monosulfate

8. Alkaban-aq

9. 29060-le

10. Vinblastine Sulphate

11. Vincaleukoblastine,sulfate(1:1)

12. Nsc-49842

13. Mls000863275

14. Vincaleukoblastine, Sulfate (1:1) (salt)

15. N00w22yo2b

16. Belvan, Vlb

17. 29060le

18. Smr000058844

19. Vincaleucoblastine Sulfate

20. Dsstox_cid_27831

21. Dsstox_rid_82594

22. Dsstox_gsid_47853

23. Uniblastin

24. Rozevin Sulfate

25. 29060 Le

26. Cas-18556-44-0

27. Vincaleukoblastine, Sulfate

28. Unii-n00w22yo2b

29. Ccris 2584

30. Vinblastinesulfate

31. Vinblastini Sulfas

32. Chembl378544

33. Ncgc00095285-01

34. Einecs 205-606-0

35. Vinblastine Sulfate [usan:usp:jan]

36. Opera_id_960

37. Ai3-52943

38. Ncgc00181127-01

39. Schembl3549

40. Mls000069550

41. Mls002153253

42. Mls002207069

43. Vinblastine Sulfate [mi]

44. Vinblastine Sulfate [jan]

45. Dtxsid601017133

46. Hms2235e07

47. Hms3403n09

48. Vinblastine Sulfate [iarc]

49. Vinblastine Sulfate [usan]

50. Vinblastine Sulfate [vandf]

51. Vinblastine Sulfate [mart.]

52. Tox21_111498

53. Tox21_112735

54. Ac-821

55. Vinblastine Sulfate [usp-rs]

56. Vinblastine Sulfate [who-dd]

57. Vinblastine Sulfate [who-ip]

58. Akos015960580

59. Tox21_111498_1

60. Tox21_112735_1

61. Cs-1365

62. Ncgc00263548-01

63. Ncgc00344583-01

64. Vinblastine Sulfate [orange Book]

65. Hy-13780

66. Vinblastine Sulfate [ep Monograph]

67. Vinblastini Sulfas [who-ip Latin]

68. Vinblastine Sulfate [usp Monograph]

69. N2255

70. 143v679

71. Sr-01000000155

72. Vinblastine Sulfate Salt, Powder, >=96% (hplc)

73. Sr-01000000155-7

74. Q27077057

75. Vinblastine Sulfate, European Pharmacopoeia (ep) Reference Standard

76. Vinblastine Sulfate, United States Pharmacopeia (usp) Reference Standard

77. Methyl (1r,9r,10s,11r,12r,19r)-11-(acetyloxy)-12-ethyl-4-[(13s,15r,17s)-17-ethyl-17-hydroxy-13-(methoxycarbonyl)-1,11-diazatetracyclo[13.3.1.0?,??.0?,??]nonadeca-4(12),5(10),6,8-tetraen-13-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.0?,?.0?,?.0??,??]nonadeca-2(7),3,5,13-tetraene-10-carboxylate; Sulfuric Acid

78. Methyl (3ar,3a1r,4r,5s,5ar,10br)-4-acetoxy-3a-ethyl-9-((5s,7r,9s)-5-ethyl-5-hydroxy-9-(methoxycarbonyl)-1,4,5,6,7,8,9,10-octahydro-2h-3,7-methano[1]azacycloundecino[5,4-b]indol-9-yl)-5-hydroxy-8-methoxy-6-methyl-3a,3a1,4,5,5a,6,11,12-octahydro-1h-indolizino[8,1-cd]carbazole-5-carboxylate Sulfate

2.3.3 Other Synonyms

1. Vincaleukoblastine Sulfate

2. Vinblastine Sulphate

3. Cellblastin

2.4 Create Date
2005-06-29
3 Chemical and Physical Properties
Molecular Weight 909.1 g/mol
Molecular Formula C46H60N4O13S
Hydrogen Bond Donor Count5
Hydrogen Bond Acceptor Count16
Rotatable Bond Count10
Exact Mass908.38775915 g/mol
Monoisotopic Mass908.38775915 g/mol
Topological Polar Surface Area237 Ų
Heavy Atom Count64
Formal Charge0
Complexity1780
Isotope Atom Count0
Defined Atom Stereocenter Count9
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Drug Information
1 of 2  
Drug NameVinblastine sulfate
PubMed HealthVinblastine
Drug LabelVinblastine sulfate is the salt of an alkaloid extracted from Vinca rosea Linn., a common flowering herb known as the periwinkle (more properly known as Catharanthus roseus G. Don). Previously, the generic name was vincaleukoblastine, abbreviated VLB...
Active IngredientVinblastine sulfate
Dosage FormInjectable
RouteInjection
Strength10mg/vial; 1mg/ml
Market StatusPrescription
CompanyFresenius Kabi Usa; Eurohlth Intl

2 of 2  
Drug NameVinblastine sulfate
PubMed HealthVinblastine
Drug LabelVinblastine sulfate is the salt of an alkaloid extracted from Vinca rosea Linn., a common flowering herb known as the periwinkle (more properly known as Catharanthus roseus G. Don). Previously, the generic name was vincaleukoblastine, abbreviated VLB...
Active IngredientVinblastine sulfate
Dosage FormInjectable
RouteInjection
Strength10mg/vial; 1mg/ml
Market StatusPrescription
CompanyFresenius Kabi Usa; Eurohlth Intl

5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Antineoplastic Agents, Phytogenic

Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. (See all compounds classified as Antineoplastic Agents, Phytogenic.)


Tubulin Modulators

Agents that interact with TUBULIN to inhibit or promote polymerization of MICROTUBULES. (See all compounds classified as Tubulin Modulators.)


5.2 FDA Pharmacological Classification
5.2.1 Pharmacological Classes
Vinca Alkaloids [CS]; Vinca Alkaloid [EPC]

API SUPPLIERS

read-more
read-more

01

Minakem

France

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMinakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

Flag France
Digital Content Digital Content
USDMF CEP/COS arrow-down JDMF EU-WC NDC KDMF VMF Others AUDIT
Minakem Comapny Banner

02

Minakem (formerly Delmar Chemicals...

Canada

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMinakem is manufacturing small molecules APIs including corticosteroids

Flag Canada
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Minakem Delmar

03

Aspen API

Netherlands

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAspen API. More than just an API™

Flag Netherlands
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT arrow-down
Aspen API Comapny Banner

04

Fine Chemicals Corporation PTY Ltd

South Africa

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

USDMF CEP/COS JDMF arrow-down EU-WC NDC arrow-down KDMF VMF Others AUDIT
Aspen API Comapny Banner

05

Zeon Pharma Industries India Pvt L...

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothZeon Pharma is a manufacturer and supplier of APIs & Intermediates.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Zeon Pharma Industries India Pvt Ltd

06

Minakem

France

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMinakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

Flag France
Digital Content Digital Content
USDMF arrow-down CEP/COS arrow-down JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
Minakem Comapny Banner

07

Hubei Honch Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

International Sweetener Colloquium
Not Confirmed
arrow

Hubei Honch Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
International Sweetener Colloquium
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
blank

08

Hubei Honch Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

International Sweetener Colloquium
Not Confirmed
arrow

Hubei Honch Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
International Sweetener Colloquium
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

09

Zhejiang Hisun Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

International Sweetener Colloquium
Not Confirmed
arrow

Zhejiang Hisun Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
International Sweetener Colloquium
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT arrow-down
blank

10

Gedeon Richter

Hungary

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

International Sweetener Colloquium
Not Confirmed
arrow

Gedeon Richter

Hungary

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
International Sweetener Colloquium
Not Confirmed
USDMF Inactive-api CEP/COS arrow-down JDMF arrow-down EU-WC NDC KDMF VMF Others AUDIT arrow-down
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-moreread-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMinakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

Flag France
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2018-03-27

Pay. Date : 2017-11-27

DMF Number : 5335

Submission : 1984-04-13

Status : Active

Type : II

Minakem Comapny Banner

02

Cipla Ltd

India

USDMF

arrow
International Sweetener Colloquium
Not Confirmed

02

Cipla Ltd

India
arrow
International Sweetener Colloquium
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 6499

Submission : 1986-07-28

Status : Inactive

Type : II

blank

03

Gedeon Richter Ltd

Hungary

USDMF

arrow
International Sweetener Colloquium
Not Confirmed

03

International Sweetener Colloquium
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 3499

Submission : 1979-04-05

Status : Inactive

Type : II

blank

04

International Sweetener Colloquium
Not Confirmed

04

International Sweetener Colloquium
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 39944

Submission : 2025-01-07

Status : Active

Type : II

blank

05

International Sweetener Colloquium
Not Confirmed

05

International Sweetener Colloquium
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 39264

Submission : 2024-03-18

Status : Active

Type : II

blank

06

Medimpex North America Inc

United Kingdom

USDMF

arrow
International Sweetener Colloquium
Not Confirmed

06

International Sweetener Colloquium
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 4978

Submission : 1983-07-06

Status : Inactive

Type : II

blank

07

International Sweetener Colloquium
Not Confirmed

07

International Sweetener Colloquium
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 4883

Submission : 1983-04-04

Status : Inactive

Type : II

blank

08

International Sweetener Colloquium
Not Confirmed

08

International Sweetener Colloquium
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 16240

Submission : 2002-11-11

Status : Inactive

Type : II

blank

09

Adithya Alkaloids Ltd

Country

USDMF

arrow
International Sweetener Colloquium
Not Confirmed

09

Adithya Alkaloids Ltd

Country
arrow
International Sweetener Colloquium
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 11284

Submission : 1995-01-03

Status : Inactive

Type : II

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

CEP/COS

read-more
read-moreread-more
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMinakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

Flag France
Digital Content Digital Content
R1-CEP 2004-073 - Rev 02
Valid
Chemical
2015-08-04
748
Minakem Comapny Banner

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMinakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

Flag France
Digital Content Digital Content

Certificate Number : R1-CEP 2004-073 - Rev 02

Status : Valid

Issue Date : 2015-08-04

Type : Chemical

Substance Number : 748

Minakem Comapny Banner
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMinakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

Flag France
Digital Content Digital Content
CEP 2020-065 - Rev 02
Valid
Chemical
2025-12-02
748
Minakem Comapny Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMinakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

Flag France
Digital Content Digital Content

Certificate Number : CEP 2020-065 - Rev 02

Status : Valid

Issue Date : 2025-12-02

Type : Chemical

Substance Number : 748

Minakem Comapny Banner

03

International Sweetener Colloquium
Not Confirmed
arrow
arrow
International Sweetener Colloquium
Not Confirmed

Certificate Number : R1-CEP 2007-300 - Rev 00

Status : Withdrawn by Holder

Issue Date : 2015-07-08

Type : Chemical

Substance Number : 748

blank

04

International Sweetener Colloquium
Not Confirmed
arrow
arrow
International Sweetener Colloquium
Not Confirmed

Certificate Number : R0-CEP 2013-352 - Rev 00

Status : Withdrawn by Holder

Issue Date : 2015-12-21

Type : Chemical

Substance Number : 748

blank

05

International Sweetener Colloquium
Not Confirmed
arrow
arrow
International Sweetener Colloquium
Not Confirmed

Certificate Number : R1-CEP 2005-261 - Rev 00

Status : Valid

Issue Date : 2011-11-04

Type : Chemical

Substance Number : 748

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

JDMF

read-more
read-moreread-more

01

Vinblastine Sulfate

Registration Number : 306MF10066

Registrant's Address : 15 Hawkins Avenue, Epping 1,7460, Cape Town, South Africa

Initial Date of Registration : 2024-05-15

Latest Date of Registration : 2024-05-15

Aspen API Comapny Banner

02

International Sweetener Colloquium
Not Confirmed
arrow
arrow
International Sweetener Colloquium
Not Confirmed

Vinblastine sulfate

Registration Number : 220MF10116

Registrant's Address : BUDAPEST, GYOMROI UT 19-21, HUNGARY

Initial Date of Registration : 2008-04-28

Latest Date of Registration : 2008-04-28

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

EU WC

read-more
read-moreread-more

01

Cipla

India
International Sweetener Colloquium
Not Confirmed
arrow

Cipla

India
arrow
International Sweetener Colloquium
Not Confirmed

Vinblastine Sulfate USP/BP/EP

Date of Issue : 2025-08-26

Valid Till : 2028-08-08

Written Confirmation Number : WC-0138

Address of the Firm : Plot No. 285, 286 & 287, Bommasandra — Jigani Link Road Industrial Area, KIADB...

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

read-more
read-moreread-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMinakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

Flag France
Digital Content Digital Content

VINBLASTINE SULFATE

NDC Package Code : 69910-0002

Start Marketing Date : 2015-06-18

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : BULK INGREDIENT

Minakem Comapny Banner

03

International Sweetener Colloquium
Not Confirmed
arrow
arrow
International Sweetener Colloquium
Not Confirmed

VINBLASTINE SULFATE

NDC Package Code : 62158-0012

Start Marketing Date : 2025-10-01

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1g/g)

Marketing Category : BULK INGREDIENT

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

Minakem

France
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMinakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

Flag France
Digital Content Digital Content

Vinblastine Sulfate

About the Company : MINAKEM is a cGMP custom manufacturer specializing in small molecule APIs, HPAPIs, and steroids. Its highly skilled R&D teams, supported by strong analytical and regulatory service...

MINAKEM is a cGMP custom manufacturer specializing in small molecule APIs, HPAPIs, and steroids. Its highly skilled R&D teams, supported by strong analytical and regulatory services, excel in process development and organic synthesis, operating under secrecy agreements to protect client IP. With three European and one Canadian production site, MINAKEM supports strategic sourcing and reshoring projects. Recently launched commercial generic APIs include Apixaban, Mirabegron, Fulvestrant, remifentanil, and esmolol. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Minakem Comapny Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMinakem is manufacturing small molecules APIs including corticosteroids

Flag Canada
Digital Content Digital Content

Vinblastine Sulfate

About the Company : Minakem Montreal is developing and manufacturing small molecules APIs and advanced intermediates, including corticosteroids. Following efficient processes and methodologies, our em...

Minakem Montreal is developing and manufacturing small molecules APIs and advanced intermediates, including corticosteroids. Following efficient processes and methodologies, our employees operate a regularly inspected cGMP facility equipped with reactors ranging from 40 to 7,600 litres. Located in Montreal, Canada, we have contributed to the success of our North-American and international clients since 1964.
Minakem Delmar

03

Aspen API

Netherlands
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAspen API. More than just an API™

Flag Netherlands
Digital Content Digital Content

Vinblastine Sulfate

About the Company : Aspen API is a cooperative entity formed by Aspen Oss in the Netherlands and Fine Chemicals Corporation in South Africa. The company supplies a broad portfolio of over 50 high-qual...

Aspen API is a cooperative entity formed by Aspen Oss in the Netherlands and Fine Chemicals Corporation in South Africa. The company supplies a broad portfolio of over 50 high-quality APIs, including high-potency products, oncology, peptides, narcotics, analgesics, botanical extractions, and biochemicals. Aspen API emphasizes quality, compliance, and teamwork, while integrating sustainable practices through the use of eco-friendly technologies and solvents in its manufacturing processes. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Aspen API Comapny Banner

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothZeon Pharma is a manufacturer and supplier of APIs & Intermediates.

Flag India
Digital Content Digital Content

Vinblastine sulphate

About the Company : Zeon Pharma Industries India Pvt. Ltd. is an ISO 9001:2015, cGMP, and WHO-GMP certified company with a dedicated manufacturing facility for Bulk Drugs (APIs), phytochemicals, herba...

Zeon Pharma Industries India Pvt. Ltd. is an ISO 9001:2015, cGMP, and WHO-GMP certified company with a dedicated manufacturing facility for Bulk Drugs (APIs), phytochemicals, herbal extracts, semi-finished granules, and finished formulations such as tablets, capsules, and dry suspensions. The company also provides product support through associate manufacturing plants for APIs, pellets, excipients, enzymes, and specialized chemicals, operating in compliance with cGMP, WHO-GMP, and EU-GMP standards. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Zeon Pharma Industries India Pvt Ltd

05

International Sweetener Colloquium
Not Confirmed
arrow
arrow
International Sweetener Colloquium
Not Confirmed

Vinblastine Sulfate

About the Company : Hubei Hongzhong Pharmaceutical Co., Ltd. was founded in 2007 and is located in Li Shizhen Pharmaceutical Industrial Park, Qichun County, Hubei Province. The company's products have...

Hubei Hongzhong Pharmaceutical Co., Ltd. was founded in 2007 and is located in Li Shizhen Pharmaceutical Industrial Park, Qichun County, Hubei Province. The company's products have been focusing on the research and development and production of the latest anti-tumor and high-end animal raw materials. In 2011, it was certified as a high-tech enterprise for the first time, has more than 20 domestic and foreign invention patents. The company is a postgraduate workstation issued by the Hubei Provincial Department of Education, and has won the Hubei Provincial Science and Technology Innovation Award and Science and Technology Progress Award.
blank

06

International Sweetener Colloquium
Not Confirmed
arrow
arrow
International Sweetener Colloquium
Not Confirmed

Vinblastine Sulfate

About the Company : Established in the year 2004, Sakar is engaged in manufacturing of Pharmaceutical products providing Liquid Orals, Cephalosporin Tablet, Capsule, Dry Powder Syrup, Dry Powder Injec...

Established in the year 2004, Sakar is engaged in manufacturing of Pharmaceutical products providing Liquid Orals, Cephalosporin Tablet, Capsule, Dry Powder Syrup, Dry Powder Injections, Liquid Injectables (SVP) in Ampoules and Vials & Lyophilized Injections. Sakar is managed by a team of professionals with an endeavour to offer Quality Pharmaceutical & Health Care Products in various countries. The company operates as contract development and manufacturing organisation (CDMO), being the EU GMP approved CMO for leading multinational pharmaceutical companies.
blank

07

International Sweetener Colloquium
Not Confirmed
arrow
arrow
International Sweetener Colloquium
Not Confirmed

Vinblastine Sulfate

About the Company : VINKEM - One Stop Solution for complete range ofOncology In-house API's & Finished dosage injectables in liquid vials andlyophilized form.State of Art cGMP facility with DMF and ...

VINKEM - One Stop Solution for complete range ofOncology In-house API's & Finished dosage injectables in liquid vials andlyophilized form.State of Art cGMP facility with DMF and ANDA support with2 to 100 ml BOSCH-Germany integrated wash-sterilising-Fill and seal line withRABS technology with IPC, 7.5 M3 Lyophilizer,& 100% SAL. Equipments & Instruments are SCADA 21-CFR Compliant with Siemen'sBio-Metric control and BMS.Offers excellent scope for investment / marketingtie-up / R&D /Contract Manufacturing.Products: Vinblastine, Vincristine,Vinorelbine, Vindesine,Paclitaxel, Docetaxel, Gemcitabine, Platin Complexes, Camptothecine Derivatives, etc.Soft gel dosage forms (Vinorelbine, Vinflunine and other products) nearing completion.
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1648665000,"product":"VINBLASTINE SULPHATE USP, BATCH-IWP22002","address":"CIPLA HOUSE, PENINSULA BUSINESS,PA RK,GANPATRAO KADAM MARG,LOWER","city":"PAREL MUMBAI MAHARASHTRA,MAHARASHTR","supplier":"CIPLA LTD","supplierCountry":"INDIA","foreign_port":"GUARULHOS","customer":"LIBBS FARMACEUTICA LTDA","customerCountry":"BRAZIL","quantity":"0.17","actualQuantity":"168","unit":"GMS","unitRateFc":"230","totalValueFC":"38126.7","currency":"USD","unitRateINR":17297.619047619046,"date":"31-Mar-2022","totalValueINR":"2906000","totalValueInUsd":"38126.7","indian_port":"BANGALORE AIR","hs_no":"29398000","bill_no":"9374281","productDescription":"API","marketType":"","country":"BRAZIL","selfForZScoreResived":"Pharma Grade","supplierPort":"BANGALORE AIR","supplierAddress":"CIPLA HOUSE, PENINSULA BUSINESS,PA RK,GANPATRAO KADAM MARG,LOWER, PAREL MUMBAI MAHARASHTRA,MAHARASHTR","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1657477800,"product":"VINBLASTINE SULPHATE USP, BATCH-IWP22003","address":"CIPLA HOUSE, PENINSULA BUSINESS,PA RK,GANPATRAO KADAM MARG,LOWER","city":"PAREL MUMBAI MAHARASHTRA,MAHARASHTR","supplier":"CIPLA LTD","supplierCountry":"INDIA","foreign_port":"GUARULHOS","customer":"LIBBS FARMACEUTICA LTDA","customerCountry":"BRAZIL","quantity":"0.26","actualQuantity":"263","unit":"GMS","unitRateFc":"230","totalValueFC":"59484.5","currency":"USD","unitRateINR":17984.790874524715,"date":"11-Jul-2022","totalValueINR":"4730000","totalValueInUsd":"59484.5","indian_port":"BANGALORE AIR","hs_no":"29398000","bill_no":"2734262","productDescription":"API","marketType":"","country":"BRAZIL","selfForZScoreResived":"Pharma Grade","supplierPort":"BANGALORE AIR","supplierAddress":"CIPLA HOUSE, PENINSULA BUSINESS,PA RK,GANPATRAO KADAM MARG,LOWER, PAREL MUMBAI MAHARASHTRA,MAHARASHTR","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1667154600,"product":"VINBLASTINE SULPHATE USP, BATCH-IWP22004","address":"CIPLA HOUSE, PENINSULA BUSINESS,PA RK,GANPATRAO KADAM MARG,LOWER","city":"PAREL MUMBAI MAHARASHTRA,MAHARASHTR","supplier":"CIPLA LTD","supplierCountry":"INDIA","foreign_port":"GUARULHOS","customer":"LIBBS FARMACEUTICA LTDA","customerCountry":"BRAZIL","quantity":"0.14","actualQuantity":"139","unit":"GMS","unitRateFc":"230","totalValueFC":"31938.1","currency":"USD","unitRateINR":18906.474820143885,"date":"31-Oct-2022","totalValueINR":"2628000","totalValueInUsd":"31938.1","indian_port":"BANGALORE AIR","hs_no":"29398000","bill_no":"5143284","productDescription":"API","marketType":"","country":"BRAZIL","selfForZScoreResived":"Pharma Grade","supplierPort":"BANGALORE AIR","supplierAddress":"CIPLA HOUSE, PENINSULA BUSINESS,PA RK,GANPATRAO KADAM MARG,LOWER, PAREL MUMBAI MAHARASHTRA,MAHARASHTR","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1670265000,"product":"VINBLASTINE SULPHATE USP, BATCH:IWP22004","address":"CIPLA HOUSE, PENINSULA BUSINESS,PA RK,GANPATRAO KADAM MARG,LOWER","city":"PAREL MUMBAI MAHARASHTRA,MAHARASHTR","supplier":"CIPLA LTD","supplierCountry":"INDIA","foreign_port":"GUARULHOS","customer":"LIBBS FARMACEUTICA LTDA","customerCountry":"BRAZIL","quantity":"0.18","actualQuantity":"177","unit":"GMS","unitRateFc":"230","totalValueFC":"39669.3","currency":"USD","unitRateINR":18468.926553672318,"date":"06-Dec-2022","totalValueINR":"3269000","totalValueInUsd":"39669.3","indian_port":"BANGALORE AIR","hs_no":"29398000","bill_no":"5956666","productDescription":"API","marketType":"","country":"BRAZIL","selfForZScoreResived":"Pharma Grade","supplierPort":"BANGALORE AIR","supplierAddress":"CIPLA HOUSE, PENINSULA BUSINESS,PA RK,GANPATRAO KADAM MARG,LOWER, PAREL MUMBAI MAHARASHTRA,MAHARASHTR","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1677177000,"product":"VINBLASTINE SULPHATE USP, BATCH:IWP23000","address":"CIPLA HOUSE, PENINSULA BUSINESS,PA RK,GANPATRAO KADAM MARG,LOWER","city":"PAREL MUMBAI MAHARASHTRA,MAHARASHTR","supplier":"CIPLA LTD","supplierCountry":"INDIA","foreign_port":"GUARULHOS","customer":"LIBBS FARMACEUTICA LTDA","customerCountry":"BRAZIL","quantity":"0.21","actualQuantity":"208","unit":"GMS","unitRateFc":"230","totalValueFC":"47439.1","currency":"USD","unitRateINR":18836.538461538461,"date":"24-Feb-2023","totalValueINR":"3918000","totalValueInUsd":"47439.1","indian_port":"BANGALORE AIR","hs_no":"29398000","bill_no":"8034214","productDescription":"API","marketType":"","country":"BRAZIL","selfForZScoreResived":"Pharma Grade","supplierPort":"BANGALORE AIR","supplierAddress":"CIPLA HOUSE, PENINSULA BUSINESS,PA RK,GANPATRAO KADAM MARG,LOWER, PAREL MUMBAI MAHARASHTRA,MAHARASHTR","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1708021800,"product":"VINBLASTINE SULPHATE USP, BATCH:IWP240001, MFG DT:JAN2024,RETEST DT:DEC2025, MLKTK\/25\/540\/2007","address":"MUMBAI CENTRAL,","city":"MUMBAI, MAHARASHTRA.","supplier":"CIPLA LTD","supplierCountry":"INDIA","foreign_port":"GUARULHOS","customer":"LIBBS FARMACEUTICA LTDA","customerCountry":"BRAZIL","quantity":"0.23","actualQuantity":"234","unit":"GMS","unitRateFc":"230","totalValueFC":"53318.1","currency":"USD","unitRateINR":18906,"date":"16-Feb-2024","totalValueINR":"4424004","totalValueInUsd":"53318.1","indian_port":"Bangalore Air","hs_no":"29398000","bill_no":"7570916","productDescription":"API","marketType":"","country":"BRAZIL","selfForZScoreResived":"Pharma Grade","supplierPort":"Bangalore Air","supplierAddress":"MUMBAI CENTRAL,, MUMBAI, MAHARASHTRA.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1712169000,"product":"VINBLASTINE SULPHATE USP, BATCH:IWP240008, MFG DT:FEB2024,EXP DT:JAN2026, ML: KTK\/25\/540\/2007","address":"MUMBAI CENTRAL,","city":"MUMBAI, MAHARASHTRA.","supplier":"CIPLA LTD","supplierCountry":"INDIA","foreign_port":"GUARULHOS","customer":"LIBBS FARMACEUTICA LTDA","customerCountry":"BRAZIL","quantity":"0.12","actualQuantity":"118","unit":"GMS","unitRateFc":"230","totalValueFC":"26731.4","currency":"USD","unitRateINR":18917.49872881356,"date":"04-Apr-2024","totalValueINR":"2232264.85","totalValueInUsd":"26731.4","indian_port":"Bangalore Air","hs_no":"29398000","bill_no":"8896976","productDescription":"API","marketType":"","country":"BRAZIL","selfForZScoreResived":"Pharma Grade","supplierPort":"Bangalore Air","supplierAddress":"MUMBAI CENTRAL,, MUMBAI, MAHARASHTRA.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1713465000,"product":"VINBLASTINE SULPHATE USP, BATCH:IWP240020, MFG DT:FEB2024,EXP DT:JAN2026, ML: KTK\/25\/540\/2007","address":"MUMBAI CENTRAL,","city":"MUMBAI, MAHARASHTRA.","supplier":"CIPLA LTD","supplierCountry":"INDIA","foreign_port":"GUARULHOS","customer":"LIBBS FARMACEUTICA LTDA","customerCountry":"BRAZIL","quantity":"0.05","actualQuantity":"45","unit":"GMS","unitRateFc":"230","totalValueFC":"10249.9","currency":"USD","unitRateINR":19021,"date":"19-Apr-2024","totalValueINR":"855945","totalValueInUsd":"10249.9","indian_port":"Bangalore Air","hs_no":"29398000","bill_no":"9237690","productDescription":"API","marketType":"","country":"BRAZIL","selfForZScoreResived":"Pharma Grade","supplierPort":"Bangalore Air","supplierAddress":"MUMBAI CENTRAL,, MUMBAI, MAHARASHTRA.","customerAddress":""},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1659292200,"product":"VINBLASTINE SULFATE IP (LIST 3 SR.NO.77)","address":"1101, 11TH FLOOR, DHUKKA CHAMBERS OFF PODDAR PARK ROAD, MALAD EAST","city":"MUMBAI","supplier":"GUANGDONG JIAHONG CO","supplierCountry":"CHINA","foreign_port":"NA","customer":"UNICHEMIE INTERNATIONAL PRIVATE LTD","customerCountry":"INDIA","quantity":"0.50","actualQuantity":"500","unit":"GMS","unitRateFc":"106","totalValueFC":"53921.1","currency":"USD","unitRateINR":"8580.7","date":"01-Aug-2022","totalValueINR":"4290350","totalValueInUsd":"53921.1","indian_port":"BOMBAY AIR","hs_no":"29398000","bill_no":"9810564","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"1101, 11TH FLOOR, DHUKKA CHAMBERS OFF PODDAR PARK ROAD, MALAD EAST"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1669573800,"product":"VINBLASTINE SULFATE IP (LIST 3 SR.NO.77)","address":"1101, 11TH FLOOR, DHUKKA CHAMBERS OFF PODDAR PARK ROAD, MALAD EAST","city":"MUMBAI","supplier":"GUANGDONG JIAHONG CO","supplierCountry":"CHINA","foreign_port":"NA","customer":"UNICHEMIE INTERNATIONAL PRIVATE LTD","customerCountry":"INDIA","quantity":"0.30","actualQuantity":"300","unit":"GMS","unitRateFc":"107.5","totalValueFC":"32640.2","currency":"USD","unitRateINR":"8879.5","date":"28-Nov-2022","totalValueINR":"2663850","totalValueInUsd":"32640.2","indian_port":"BOMBAY AIR","hs_no":"29398000","bill_no":"3505959","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"1101, 11TH FLOOR, DHUKKA CHAMBERS OFF PODDAR PARK ROAD, MALAD EAST"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q2","strtotime":1680805800,"product":"VINBLASTINE SULFATE IP (LIST 3 SR.NO.77)","address":"1101, 11TH FLOOR, DHUKKA CHAMBERS OFF PODDAR PARK ROAD, MALAD EAST","city":"MUMBAI","supplier":"GUANGDONG JIAHONG CO","supplierCountry":"CHINA","foreign_port":"NA","customer":"UNICHEMIE INTERNATIONAL PRIVATE LTD","customerCountry":"INDIA","quantity":"0.20","actualQuantity":"200","unit":"GMS","unitRateFc":"106.5","totalValueFC":"21532.9","currency":"USD","unitRateINR":"8823.5","date":"07-Apr-2023","totalValueINR":"1764705","totalValueInUsd":"21532.9","indian_port":"BOMBAY AIR","hs_no":"29398000","bill_no":"5417466","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"1101, 11TH FLOOR, DHUKKA CHAMBERS OFF PODDAR PARK ROAD, MALAD EAST"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1693765800,"product":"VINBLASTINE SULFATE IP (LIST 3 SR.NO.77)","address":"1101, 11TH FLOOR, DHUKKA CHAMBERS","city":"MUMBAI","supplier":"GUANGDONG JIAHONG CO","supplierCountry":"CHINA","foreign_port":"HONG KONG","customer":"UNICHEMIE INTERNATIONAL PRIVATE LTD","customerCountry":"INDIA","quantity":"0.25","actualQuantity":"250","unit":"GMS","unitRateFc":"107.5","totalValueFC":"27163.7","currency":"USD","unitRateINR":"9019.3","date":"04-Sep-2023","totalValueINR":"2254812.5","totalValueInUsd":"27163.7","indian_port":"Bombay Air","hs_no":"29398000","bill_no":"7672924","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HONG KONG","supplierAddress":"18\/F HAIJIAO BUILDING, NO.93 TIANHEROAD,GUANGZHOU,CHINASDNF China","customerAddress":"1101, 11TH FLOOR, DHUKKA CHAMBERS"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1695925800,"product":"VINBLASTINE SULFATE IP (LIST 3 SR.NO.77)","address":"1101, 11TH FLOOR, DHUKKA CHAMBERS","city":"MUMBAI","supplier":"GUANGDONG JIAHONG CO","supplierCountry":"CHINA","foreign_port":"HONG KONG","customer":"UNICHEMIE INTERNATIONAL PRIVATE LTD","customerCountry":"INDIA","quantity":"0.15","actualQuantity":"150","unit":"GMS","unitRateFc":"107.5","totalValueFC":"16327.4","currency":"USD","unitRateINR":"9035.4","date":"29-Sep-2023","totalValueINR":"1355306.25","totalValueInUsd":"16327.4","indian_port":"Bombay Air","hs_no":"29398000","bill_no":"8070538","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HONG KONG","supplierAddress":"18\/F HAIJIAO BUILDING, NO.93 TIANHEROAD,GUANGZHOU,CHINASDNF China","customerAddress":"1101, 11TH FLOOR, DHUKKA CHAMBERS"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1702837800,"product":"VINBLASTINE SULFATE IP","address":"1101, 11TH FLOOR, DHUKKA CHAMBERS","city":"MUMBAI","supplier":"GUANGDONG JIAHONG CO","supplierCountry":"CHINA","foreign_port":"HONG KONG","customer":"UNICHEMIE INTERNATIONAL PRIVATE LTD","customerCountry":"INDIA","quantity":"0.10","actualQuantity":"100","unit":"GMS","unitRateFc":"107.5","totalValueFC":"10886.5","currency":"USD","unitRateINR":"9062.3","date":"18-Dec-2023","totalValueINR":"906225","totalValueInUsd":"10886.5","indian_port":"Bombay Air","hs_no":"29398000","bill_no":"9285435","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HONG KONG","supplierAddress":"18\/F HAIJIAO BUILDING,NO.93 TIANHEROAD, GUANGZHOU,CHINASDNF China","customerAddress":"1101, 11TH FLOOR, DHUKKA CHAMBERS"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1711045800,"product":"VINBLASTINE SULFATE","address":"VILLAGE NAG KALAN,MAJITHA ROAD,MAJ","city":"AMRITSAR,PUNJAB","supplier":"ZHEJIANG SHINDAI CHEMICALS CO LTD","supplierCountry":"CHINA","foreign_port":"HONG KONG","customer":"KWALITY PHARMACEUTICALS LTD","customerCountry":"INDIA","quantity":"0.03","actualQuantity":"25","unit":"GMS","unitRateFc":"120","totalValueFC":"3025.8","currency":"USD","unitRateINR":"10050","date":"22-Mar-2024","totalValueINR":"251250","totalValueInUsd":"3025.8","indian_port":"Delhi Air","hs_no":"29339990","bill_no":"2698593","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HONG KONG","supplierAddress":"24A, NO. 25 JUYE ROAD, BINJIANGDSITRICT, HANGZHOU CHINASDNF SDNF","customerAddress":"VILLAGE NAG KALAN,MAJITHA ROAD,MAJ"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1715884200,"product":"VINBLASTINE SULFATE IP (LIST 3 SR.NO.77)","address":"1101, 11TH FLOOR, DHUKKA CHAMBERS","city":"MUMBAI","supplier":"GUANGDONG JIAHONG CO","supplierCountry":"CHINA","foreign_port":"HONG KONG","customer":"UNICHEMIE INTERNATIONAL PRIVATE LTD","customerCountry":"INDIA","quantity":"0.30","actualQuantity":"300","unit":"GMS","unitRateFc":"107.5","totalValueFC":"32635.3","currency":"USD","unitRateINR":"9067.6","date":"17-May-2024","totalValueINR":"2720287.5","totalValueInUsd":"32635.3","indian_port":"Bombay Air","hs_no":"29398000","bill_no":"3530199","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HONG KONG","supplierAddress":"18\/F HAIJIAO BUILDING,NO.93 TIANHYEROAD, GUANGZHOU,CHINASDNF China","customerAddress":"1101, 11TH FLOOR, DHUKKA CHAMBERS"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1718130600,"product":"VINBLASTINE SULFATE IP (LIST 3 SR.NO.77)","address":"1101, 11TH FLOOR, DHUKKA CHAMBERS","city":"MUMBAI","supplier":"GUANGDONG JIAHONG CO","supplierCountry":"CHINA","foreign_port":"HONG KONG","customer":"UNICHEMIE INTERNATIONAL PRIVATE LTD","customerCountry":"INDIA","quantity":"0.10","actualQuantity":"100","unit":"GMS","unitRateFc":"107.5","totalValueFC":"10855.7","currency":"USD","unitRateINR":"9062.3","date":"12-Jun-2024","totalValueINR":"906225","totalValueInUsd":"10855.7","indian_port":"Bombay Air","hs_no":"29398000","bill_no":"3951863","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HONG KONG","supplierAddress":"18\/F HAIJIAO BUILDING,NO.93 TIANHEROAD, GUANGZHOU,CHINASDNF China","customerAddress":"1101, 11TH FLOOR, DHUKKA CHAMBERS"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1738693800,"product":"VINBLASTINE SULFATE, (LIC NO.SW\/OD\/11\/2024\/000005502), LOT NO:2420400030, (QTY:22GRAMS)VINBLASTINE SULFATE, (LIC NO.SW\/OD\/11\/2024\/000005502), LOT N","address":"PLOT NO 113 114, IIND FLOOR,","city":"KUKATPALLY, HYDERABAD. AP.","supplier":"MINAKEM HIGH POTENT","supplierCountry":"BELGIUM","foreign_port":"BRUSSELS","customer":"RICONPHARMA INDIA PRIVATE LTD","customerCountry":"INDIA","quantity":"0.02","actualQuantity":"22","unit":"GMS","unitRateFc":"595","totalValueFC":"13110.5","currency":"USD","unitRateINR":"51824.5","date":"05-Feb-2025","totalValueINR":"1140139","totalValueInUsd":"13110.5","indian_port":"Hyderabad Air","hs_no":"29339990","bill_no":"8190951","productDescription":"API","marketType":"REGULATED MARKET","country":"BELGIUM","selfForZScoreResived":"Pharma Grade","supplierPort":"BRUSSELS","supplierAddress":"8 RUE FONDS JEAN PAQUES 1435 MONT SAINT GUIBERT - BELGIUM SDNF BE","customerAddress":"PLOT NO 113 114, IIND FLOOR,"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q2","strtotime":1747679400,"product":"VINBLASTINE SULFATE (CAS NO. 143-67-9) VINBLASTINE SULFATE (CAS NO. 143-67-9)","address":"VILLAGE NAG KALAN,MAJITHA ROAD,MAJ","city":"AMRITSAR,PUNJAB","supplier":"NINGBO SANGER MEDTECH COLTD","supplierCountry":"CHINA","foreign_port":"BEIJING","customer":"KWALITY PHARMACEUTICALS LTD","customerCountry":"INDIA","quantity":"0.03","actualQuantity":"0.03","unit":"KGS","unitRateFc":"113000","totalValueFC":"3437.7","currency":"USD","unitRateINR":"9763200","date":"20-May-2025","totalValueINR":"292896","totalValueInUsd":"3437.7","indian_port":"Delhi Air","hs_no":"29339990","bill_no":"2173012","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BEIJING","supplierAddress":"7-1-20 NO. 666 SANGTIAN ROAD NINGBO 315040 CHINA SDNF SDNF","customerAddress":"VILLAGE NAG KALAN,MAJITHA ROAD,MAJ"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q2","strtotime":1749407400,"product":"VINBLASTINE SULFATE IP (LIST 3 SR.NO.77) VINBLASTINE SULFATE IP (LIST 3 SR.NO.77)","address":"1101, 11TH FLOOR, DHUKKA CHAMBERS","city":"MUMBAI","supplier":"GUANGDONG JIAHONG CO","supplierCountry":"CHINA","foreign_port":"HONG KONG","customer":"UNICHEMIE INTERNATIONAL PRIVATE LTD","customerCountry":"INDIA","quantity":"0.10","actualQuantity":"100","unit":"GMS","unitRateFc":"98","totalValueFC":"9894","currency":"USD","unitRateINR":"8501.5","date":"09-Jun-2025","totalValueINR":"850150","totalValueInUsd":"9894","indian_port":"Bombay Air","hs_no":"29398000","bill_no":"2543415","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HONG KONG","supplierAddress":"18\/F HAIJIAO BUILDING, NO.93 TIANHE ROAD,GUANGZHOU,CHINA SDNF China","customerAddress":"1101, 11TH FLOOR, DHUKKA CHAMBERS"},{"dataSource":"API Import","activeIngredients":"","year":"2026","qtr":"Q1","strtotime":1768501800,"product":"VINBLASTINE SULFATE IP (LIST 2 SR.NO.54) VINBLASTINE SULFATE IP (LIST 2 SR.NO.54)","address":"1101, 11TH FLOOR, DHUKKA CHAMBERS","city":"MUMBAI","supplier":"GUANGDONG JIAHONG CO","supplierCountry":"CHINA","foreign_port":"HONG KONG","customer":"UNICHEMIE INTERNATIONAL PRIVATE LTD","customerCountry":"INDIA","quantity":"0.10","actualQuantity":"100","unit":"GMS","unitRateFc":"102","totalValueFC":"10252.2","currency":"USD","unitRateINR":"9302.4","date":"16-Jan-2026","totalValueINR":"930240","totalValueInUsd":"10252.2","indian_port":"Bombay Air","hs_no":"29398000","bill_no":"8","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HONG KONG","supplierAddress":"18\/F HAIJIAO BUILDING, NO.93 TIANHE ROAD,GUANGZHOU,CHINA SDNF China","customerAddress":"1101, 11TH FLOOR, DHUKKA CHAMBERS"}]
31-Mar-2022
16-Jan-2026
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API/FDF Prices: Book a Demo to explore the features and consider upgrading later

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Drugs in Development

read-more
read-more

Details:

Nivolumab, an antibody targeting PD-1, shows promise in treating Classical Hodgkin lymphoma.


Lead Product(s): Nivolumab,Doxorubicin Hydrochloride,Vinblastine Sulfate,Dacarbazine

Therapeutic Area: Oncology Brand Name: Opdivo

Study Phase: Phase IIIProduct Type: Antibody, Unconjugated

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable December 11, 2025

blank

01

International Sweetener Colloquium
Not Confirmed
International Sweetener Colloquium
Not Confirmed

Details : Nivolumab, an antibody targeting PD-1, shows promise in treating Classical Hodgkin lymphoma.

Product Name : Opdivo

Product Type : Antibody, Unconjugated

Upfront Cash : Inapplicable

December 11, 2025

blank

Details:

The proceeds from the offering will be used to fund the clinical development of Cisplatin, a cytotoxic drug targeting DNA, to advance cancer treatment.


Lead Product(s): Cisplatin,Vinblastine Sulfate

Therapeutic Area: Oncology Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Cytotoxic Drug

Sponsor: Alliance Global Partners

Deal Size: $4.0 million Upfront Cash: Undisclosed

Deal Type: Public Offering October 31, 2025

blank

02

International Sweetener Colloquium
Not Confirmed
International Sweetener Colloquium
Not Confirmed

Details : The proceeds from the offering will be used to fund the clinical development of Cisplatin, a cytotoxic drug targeting DNA, to advance cancer treatment.

Product Name : Undisclosed

Product Type : Cytotoxic Drug

Upfront Cash : Undisclosed

October 31, 2025

blank
  • Development Update

Details:

Vinblastine is a Other Small Molecule drug candidate, which is currently being evaluated in Phase II clinical studies for the treatment of Lymphoma, Large-Cell, Anaplastic.


Lead Product(s): Vinblastine Sulfate,Brentuximab Vedotin,Nivolumab

Therapeutic Area: Oncology Brand Name: Undisclosed

Study Phase: Phase IIProduct Type: Miscellaneous

Sponsor: University of Alabama at Birmingham | Helen DeVos Children's Hospital | Nationwide Children’s Hospital | Memorial Sloan Kettering Cancer Center | University of Utah | Ohio State University

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable June 10, 2025

blank

03

New York Medical College

Country
arrow
International Sweetener Colloquium
Not Confirmed

New York Medical College

Country
arrow
International Sweetener Colloquium
Not Confirmed

Lead Product(s) : Vinblastine Sulfate,Brentuximab Vedotin,Nivolumab

Therapeutic Area : Oncology

Highest Development Status : Phase II

Partner/Sponsor/Collaborator : University of Alabama at Birmingham | Helen DeVos Children's Hospital | Nationwide Children’s Hospital | Memorial Sloan Kettering Cancer Center | University of Utah | Ohio State University

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : Vinblastine is a Other Small Molecule drug candidate, which is currently being evaluated in Phase II clinical studies for the treatment of Lymphoma, Large-Cell, Anaplastic.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

June 10, 2025

blank

Details:

Durvalumab is a Antibody drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Urinary Bladder Neoplasms.


Lead Product(s): Durvalumab,Methotrexate,Vinblastine Sulfate,Doxorubicin Hydrochloride,Cisplatin

Therapeutic Area: Oncology Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Antibody, Unconjugated

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable May 07, 2025

blank

04

AstraZeneca

United Kingdom
arrow
International Sweetener Colloquium
Not Confirmed

AstraZeneca

United Kingdom
arrow
International Sweetener Colloquium
Not Confirmed

Details : Durvalumab is a Antibody drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Urinary Bladder Neoplasms.

Product Name : Undisclosed

Product Type : Antibody, Unconjugated

Upfront Cash : Inapplicable

May 07, 2025

blank

Details:

Brentuximab Vedotin is a Antibody-drug Conjugate drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Hodgkin Disease.


Lead Product(s): Brentuximab Vedotin,Doxorubicin Hydrochloride,Vinblastine Sulfate,Dacarbazine

Therapeutic Area: Oncology Brand Name: Undisclosed

Study Phase: Phase IVProduct Type: Antibody-drug Conjugate

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable February 18, 2025

blank

05

International Sweetener Colloquium
Not Confirmed
International Sweetener Colloquium
Not Confirmed

Details : Brentuximab Vedotin is a Antibody-drug Conjugate drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Hodgkin Disease.

Product Name : Undisclosed

Product Type : Antibody-drug Conjugate

Upfront Cash : Inapplicable

February 18, 2025

blank
  • Development Update

Details:

Methotrexate is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Urinary Bladder Neoplasms.


Lead Product(s): Methotrexate,Vinblastine Sulfate,Doxorubicin Hydrochloride,Cisplatin,Gemcitabine,Avelumab

Therapeutic Area: Oncology Brand Name: Undisclosed

Study Phase: Phase IIProduct Type: Cytotoxic Drug

Sponsor: Merck Group

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable November 13, 2024

blank

06

American University of Beirut Medical Center

Country
arrow
International Sweetener Colloquium
Not Confirmed

American University of Beirut Medical Center

Country
arrow
International Sweetener Colloquium
Not Confirmed

Details : Methotrexate is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Urinary Bladder Neoplasms.

Product Name : Undisclosed

Product Type : Cytotoxic Drug

Upfront Cash : Inapplicable

November 13, 2024

blank

Details:

The collaboration aims to conduct a phase 2 trial evaluating the clinical and biological effects of intratumoral INT230-6 in early-stage triple-negative breast cancer.


Lead Product(s): Cisplatin,2-Hydroxybenzoyl Amino Octanoate,Vinblastine Sulfate

Therapeutic Area: Oncology Brand Name: Undisclosed

Study Phase: Phase IIProduct Type: Cytotoxic Drug

Sponsor: SAKK

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Collaboration May 13, 2024

blank

07

International Sweetener Colloquium
Not Confirmed
International Sweetener Colloquium
Not Confirmed

Details : The collaboration aims to conduct a phase 2 trial evaluating the clinical and biological effects of intratumoral INT230-6 in early-stage triple-negative breast cancer.

Product Name : Undisclosed

Product Type : Cytotoxic Drug

Upfront Cash : Undisclosed

May 13, 2024

blank

Details:

Brentuximab Vedotin is a Antibody-drug Conjugate drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Hodgkin Disease.


Lead Product(s): Brentuximab Vedotin,Doxorubicin Hydrochloride,Vinblastine Sulfate,Dacarbazine,Pembrolizumab,Gemcitabine,Vinorelbine Tartrate

Therapeutic Area: Oncology Brand Name: Undisclosed

Study Phase: Phase IIProduct Type: Antibody-drug Conjugate

Sponsor: Pfizer Inc

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable April 22, 2024

blank

08

International Sweetener Colloquium
Not Confirmed
International Sweetener Colloquium
Not Confirmed

Details : Brentuximab Vedotin is a Antibody-drug Conjugate drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Hodgkin Disease.

Product Name : Undisclosed

Product Type : Antibody-drug Conjugate

Upfront Cash : Inapplicable

April 22, 2024

blank

Details:

Adcetris (brentuximab vedotin) is an antibody-drug conjugate (ADC) comprised of a CD30-directed monoclonal antibody attached by a protease-cleavable linker to a microtubule disrupting agent, which being investigated for treatment of Hodgkin lymphoma.


Lead Product(s): Brentuximab Vedotin,Doxorubicin Hydrochloride,Vinblastine Sulfate

Therapeutic Area: Oncology Brand Name: Adcetris

Study Phase: Approved FDFProduct Type: Antibody-drug Conjugate

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable October 18, 2023

blank

09

International Sweetener Colloquium
Not Confirmed
International Sweetener Colloquium
Not Confirmed

Details : Adcetris (brentuximab vedotin) is an antibody-drug conjugate (ADC) comprised of a CD30-directed monoclonal antibody attached by a protease-cleavable linker to a microtubule disrupting agent, which being investigated for treatment of Hodgkin lymphoma.

Product Name : Adcetris

Product Type : Antibody-drug Conjugate

Upfront Cash : Inapplicable

October 18, 2023

blank

Details:

ADCETRIS (brentuximab vedotin) is an antibody-drug conjugate (ADC) comprised of a CD30-directed monoclonal antibody attached by a protease-cleavable linker to a microtubule disrupting agent, which being investigated for treatment of Hodgkin lymphoma.


Lead Product(s): Brentuximab Vedotin,Doxorubicin Hydrochloride,Vinblastine Sulfate

Therapeutic Area: Oncology Brand Name: Adcetris

Study Phase: Approved FDFProduct Type: Antibody-drug Conjugate

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable September 18, 2023

blank

10

International Sweetener Colloquium
Not Confirmed
International Sweetener Colloquium
Not Confirmed

Details : ADCETRIS (brentuximab vedotin) is an antibody-drug conjugate (ADC) comprised of a CD30-directed monoclonal antibody attached by a protease-cleavable linker to a microtubule disrupting agent, which being investigated for treatment of Hodgkin lymphoma.

Product Name : Adcetris

Product Type : Antibody-drug Conjugate

Upfront Cash : Inapplicable

September 18, 2023

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

read-more
read-more

01

International Sweetener Colloquium
Not Confirmed
arrow
arrow
International Sweetener Colloquium
Not Confirmed

VINBLASTINE SULFATE

Brand Name : VINBLASTINE SULFATE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 10MG/VIAL

Packaging :

Approval Date : 1985-11-18

Application Number : 89011

Regulatory Info : DISCN

Registration Country : USA

blank

02

Accure Labs

India
International Sweetener Colloquium
Not Confirmed
arrow

Accure Labs

India
arrow
International Sweetener Colloquium
Not Confirmed

Vinblastine Sulfate

Brand Name :

Dosage Form : INJECTION

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

03

Eli Lilly

U.S.A
International Sweetener Colloquium
Not Confirmed
arrow

Eli Lilly

U.S.A
arrow
International Sweetener Colloquium
Not Confirmed

VINBLASTINE SULFATE

Brand Name : VELBAN

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 10MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1982-01-01

Application Number : 12665

Regulatory Info : DISCN

Registration Country : USA

blank

04

International Sweetener Colloquium
Not Confirmed
arrow
arrow
International Sweetener Colloquium
Not Confirmed

VINBLASTINE SULFATE

Brand Name : VINBLASTINE SULFATE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 1MG/ML

Packaging :

Approval Date : 1987-04-29

Application Number : 89515

Regulatory Info : RX

Registration Country : USA

blank

05

Hikma Pharmaceuticals

United Kingdom
International Sweetener Colloquium
Not Confirmed
arrow

Hikma Pharmaceuticals

United Kingdom
arrow
International Sweetener Colloquium
Not Confirmed

VINBLASTINE SULFATE

Brand Name : VINBLASTINE SULFATE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 10MG/VIAL

Packaging :

Approval Date : 1987-04-09

Application Number : 89395

Regulatory Info : RX

Registration Country : USA

blank

06

International Sweetener Colloquium
Not Confirmed
arrow
arrow
International Sweetener Colloquium
Not Confirmed

VINBLASTINE SULFATE

Brand Name : VINBLASTINE SULFATE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 10MG/VIAL

Packaging :

Approval Date : 1987-08-18

Application Number : 89565

Regulatory Info : DISCN

Registration Country : USA

blank

07

Quad Pharma

South Africa
International Sweetener Colloquium
Not Confirmed
arrow

Quad Pharma

South Africa
arrow
International Sweetener Colloquium
Not Confirmed

VINBLASTINE SULFATE

Brand Name : VINBLASTINE SULFATE

Dosage Form : Injectable; Injection

Dosage Strength : 1MG/ML

Packaging :

Approval Date :

Application Number : 89311

Regulatory Info :

Registration Country : USA

blank

08

Quad Pharma

South Africa
International Sweetener Colloquium
Not Confirmed
arrow

Quad Pharma

South Africa
arrow
International Sweetener Colloquium
Not Confirmed

VINBLASTINE SULFATE

Brand Name : VINBLASTINE SULFATE

Dosage Form : Injectable; Injection

Dosage Strength : 10MG/VIAL

Packaging :

Approval Date :

Application Number : 89365

Regulatory Info :

Registration Country : USA

blank

09

International Sweetener Colloquium
Not Confirmed
arrow
arrow
International Sweetener Colloquium
Not Confirmed

Vinblastine Sulfate

Brand Name : Vinblastine

Dosage Form : Vinblastine 10Mg 10Ml 1 Units Parenteral Use

Dosage Strength : 1 vial EV 10 mg 10 ml 1 mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

10

International Sweetener Colloquium
Not Confirmed
arrow
arrow
International Sweetener Colloquium
Not Confirmed

Vinblastine Sulfate

Brand Name :

Dosage Form : Injection

Dosage Strength : 10MG/10ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

read-more
read-more

01

International Sweetener Colloquium
Not Confirmed
arrow
arrow
International Sweetener Colloquium
Not Confirmed

VINBLASTINE SULFATE

Brand Name : VINBLASTINE SULFATE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 10MG/VIAL

Approval Date : 1985-11-18

Application Number : 89011

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank

02

LILLY

U.S.A
International Sweetener Colloquium
Not Confirmed
arrow

LILLY

U.S.A
arrow
International Sweetener Colloquium
Not Confirmed

VINBLASTINE SULFATE

Brand Name : VELBAN

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 10MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Approval Date : 1982-01-01

Application Number : 12665

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

blank

03

International Sweetener Colloquium
Not Confirmed
arrow
arrow
International Sweetener Colloquium
Not Confirmed

VINBLASTINE SULFATE

Brand Name : VINBLASTINE SULFATE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 1MG/ML

Approval Date : 1987-04-29

Application Number : 89515

RX/OTC/DISCN : RX

RLD : No

TE Code :

blank

04

HIKMA

United Kingdom
International Sweetener Colloquium
Not Confirmed
arrow

HIKMA

United Kingdom
arrow
International Sweetener Colloquium
Not Confirmed

VINBLASTINE SULFATE

Brand Name : VINBLASTINE SULFATE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 10MG/VIAL

Approval Date : 1987-04-09

Application Number : 89395

RX/OTC/DISCN : RX

RLD : No

TE Code :

blank

05

HOSPIRA

U.S.A
International Sweetener Colloquium
Not Confirmed
arrow

HOSPIRA

U.S.A
arrow
International Sweetener Colloquium
Not Confirmed

VINBLASTINE SULFATE

Brand Name : VINBLASTINE SULFATE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 10MG/VIAL

Approval Date : 1987-08-18

Application Number : 89565

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank

06

QUAD PHARMS

South Africa
International Sweetener Colloquium
Not Confirmed
arrow

QUAD PHARMS

South Africa
arrow
International Sweetener Colloquium
Not Confirmed

VINBLASTINE SULFATE

Brand Name : VINBLASTINE SULFATE

Dosage Form : Injectable; Injection

Dosage Strength : 1MG/ML

Approval Date :

Application Number : 89311

RX/OTC/DISCN :

RLD :

TE Code :

blank

07

QUAD PHARMS

South Africa
International Sweetener Colloquium
Not Confirmed
arrow

QUAD PHARMS

South Africa
arrow
International Sweetener Colloquium
Not Confirmed

VINBLASTINE SULFATE

Brand Name : VINBLASTINE SULFATE

Dosage Form : Injectable; Injection

Dosage Strength : 10MG/VIAL

Approval Date :

Application Number : 89365

RX/OTC/DISCN :

RLD :

TE Code :

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Europe

read-more
read-more

01

Orifarm A/S

Denmark
International Sweetener Colloquium
Not Confirmed
arrow

Orifarm A/S

Denmark
arrow
International Sweetener Colloquium
Not Confirmed

Vinblastine Sulphate

Brand Name : Choose

Dosage Form : Powder For Solution For Injection

Dosage Strength : 10mg

Packaging :

Approval Date : 10-03-2023

Application Number : 28106648521

Regulatory Info : Prescription

Registration Country : Denmark

blank

02

Spirig Healthcare Ag

Switzerland
International Sweetener Colloquium
Not Confirmed
arrow

Spirig Healthcare Ag

Switzerland
arrow
International Sweetener Colloquium
Not Confirmed

Vinblastine Sulfate

Brand Name : Velbe

Dosage Form : Powder For Solution For Injection

Dosage Strength : 10mg

Packaging :

Approval Date : 23/05/1961

Application Number : 27821

Regulatory Info : Allowed

Registration Country : Switzerland

blank

03

International Sweetener Colloquium
Not Confirmed
arrow
arrow
International Sweetener Colloquium
Not Confirmed

Vinblastine Sulfate

Brand Name : Vinblastina Stada

Dosage Form : Powder For Injectable Solution

Dosage Strength : 10MG

Packaging :

Approval Date : 01-01-1962

Application Number : 37275

Regulatory Info : Authorized

Registration Country : Spain

blank

04

International Sweetener Colloquium
Not Confirmed
arrow
arrow
International Sweetener Colloquium
Not Confirmed

Vinblastine Sulphate

Brand Name : Choose

Dosage Form : Powder For Solution For Injection

Dosage Strength : 10mg

Packaging :

Approval Date : 28-03-1962

Application Number : 28100366461

Regulatory Info : Prescription

Registration Country : Denmark

blank

05

International Sweetener Colloquium
Not Confirmed
arrow
arrow
International Sweetener Colloquium
Not Confirmed

Vinblastine Sulfate

Brand Name : Velbe

Dosage Form : Powder For Solution For Injection

Dosage Strength : 10mg

Packaging :

Approval Date : 31-12-1963

Application Number : 1.96E+13

Regulatory Info : Approved

Registration Country : Sweden

blank

06

International Sweetener Colloquium
Not Confirmed
arrow
arrow
International Sweetener Colloquium
Not Confirmed

Vinblastine Sulfate

Brand Name : Vinblastine

Dosage Form : Vinblastine 10Mg 10Ml 1 Units Parenteral Use

Dosage Strength : 1 vial EV 10 mg 10 ml 1 mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

07

International Sweetener Colloquium
Not Confirmed
arrow
arrow
International Sweetener Colloquium
Not Confirmed

Vinblastine

Brand Name : Vinblastine Teva

Dosage Form : Solution For Injection

Dosage Strength : 1mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

08

CRINOS SpA

Country
International Sweetener Colloquium
Not Confirmed
arrow

CRINOS SpA

Country
arrow
International Sweetener Colloquium
Not Confirmed

Vinblastine Sulfate

Brand Name : Velbe

Dosage Form : Vinblastine 10Mg 1 Unit Parenteral Use

Dosage Strength : 1 ampoule EV 10 mg Groun

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

09

Hospira UK Limited

Country
International Sweetener Colloquium
Not Confirmed
arrow

Hospira UK Limited

Country
arrow
International Sweetener Colloquium
Not Confirmed

Vinblastine Sulfate

Brand Name : Vinblastine Sulphate

Dosage Form : Solution For Injection

Dosage Strength : 1MG/ML

Packaging :

Approval Date : 2007-07-02

Application Number :

Regulatory Info : Invalid

Registration Country : Malta

blank

10

Central Procurement & Supplies Unit

Country
International Sweetener Colloquium
Not Confirmed
arrow

Central Procurement & Supplies Unit

Country
arrow
International Sweetener Colloquium
Not Confirmed

Vinblastine Sulfate

Brand Name : Vinblastine Sulphate Teva

Dosage Form : Solution For Injection

Dosage Strength : 1MG/ML

Packaging :

Approval Date : 2024-08-14

Application Number :

Regulatory Info : Authorised

Registration Country : Malta

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Canada

read-more
read-more

01

International Sweetener Colloquium
Not Confirmed
arrow
arrow
International Sweetener Colloquium
Not Confirmed

VINBLASTINE SULFATE

Brand Name : VINBLASTINE SULFATE INJECTION

Dosage Form : SOLUTION

Dosage Strength : 1MG/ML

Packaging : 10ML

Approval Date :

Application Number : 2183056

Regulatory Info : Prescription

Registration Country : Canada

blank

02

International Sweetener Colloquium
Not Confirmed
arrow
arrow
International Sweetener Colloquium
Not Confirmed

VINBLASTINE SULFATE

Brand Name : VINBLASTINE SULPHATE INJECTION

Dosage Form : SOLUTION

Dosage Strength : 1MG/ML

Packaging : 13.5ML VIAL

Approval Date :

Application Number : 2401460

Regulatory Info : Prescription

Registration Country : Canada

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Dossiers

read-more
read-more

01

International Sweetener Colloquium
Not Confirmed
arrow
arrow
International Sweetener Colloquium
Not Confirmed

Vinblastine Sulfate

Brand Name :

Dosage Form : INJECTION

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

01

International Sweetener Colloquium
Not Confirmed
arrow
arrow
International Sweetener Colloquium
Not Confirmed

Vinblastine Sulfate

Dosage : INJECTION

Dosage Strength : 10MG

Brand Name :

Approval Date :

Application Number :

Registration Country : India

blank

02

International Sweetener Colloquium
Not Confirmed
arrow
arrow
International Sweetener Colloquium
Not Confirmed

Vinblastine Sulfate

Brand Name :

Dosage Form : Lyophilised Injection

Dosage Strength : 10MG/Vial

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

02

International Sweetener Colloquium
Not Confirmed
arrow
arrow
International Sweetener Colloquium
Not Confirmed

Vinblastine Sulfate

Dosage : Lyophilised Injection

Dosage Strength : 10MG/Vial

Brand Name :

Approval Date :

Application Number :

Registration Country : India

blank

03

International Sweetener Colloquium
Not Confirmed
arrow
arrow
International Sweetener Colloquium
Not Confirmed

Vinblastine Sulfate

Brand Name :

Dosage Form : Injection

Dosage Strength : 10MG

Packaging : 10 ml + 0.9% w/v Sodium Chloride

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

03

International Sweetener Colloquium
Not Confirmed
arrow
arrow
International Sweetener Colloquium
Not Confirmed

Vinblastine Sulfate

Dosage : Injection

Dosage Strength : 10MG

Brand Name :

Approval Date :

Application Number :

Registration Country : India

blank

04

International Sweetener Colloquium
Not Confirmed
arrow
arrow
International Sweetener Colloquium
Not Confirmed

Vinblastine Sulfate

Brand Name :

Dosage Form : Injection

Dosage Strength : 10MG/10ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

04

International Sweetener Colloquium
Not Confirmed
arrow
arrow
International Sweetener Colloquium
Not Confirmed

Vinblastine Sulfate

Dosage : Injection

Dosage Strength : 10MG/10ML

Brand Name :

Approval Date :

Application Number :

Registration Country : India

blank

05

International Sweetener Colloquium
Not Confirmed
arrow
arrow
International Sweetener Colloquium
Not Confirmed

Vinblastine Sulfate

Brand Name :

Dosage Form : Lyophilized Injection

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

05

International Sweetener Colloquium
Not Confirmed
arrow
arrow
International Sweetener Colloquium
Not Confirmed

Vinblastine Sulfate

Dosage : Lyophilized Injection

Dosage Strength : 10MG

Brand Name :

Approval Date :

Application Number :

Registration Country : India

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Parenteral

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

Grade : Parenteral, Oral, Topical

Category : Parenteral, Solubilizers, Topical

02

Kirsch Pharma

Germany
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHigh-quality raw materials and custom blends for pharma, biopharma, nutrition, veterinary, and cosmetics worldwide.

Grade : Biopharma Grade

Category : Parenteral

Brand Name : Sodium Chloride

Excipient Details : Used as an osmolarity agent in culture media, tonicity adjuster in ophthalmics and parenterals solutions.

Pharmacopoeia Ref : On Request

Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised pa...

arrow

03

Finar

India
International Sweetener Colloquium
Not Confirmed
arrow

04

Actylis

U.S.A
International Sweetener Colloquium
Not Confirmed
arrow

05

Actylis

U.S.A
International Sweetener Colloquium
Not Confirmed
arrow

Topical

read-more
read-more

Solubilizers

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more
US drug shortages hit record high in Q1 2024, impacts cancer, ADHD drugs; Lilly, Novo ramp up production
Drug shortages are threatening healthcare systems the world over. Be it the US, Canada, Europe or Africa, drug scarcities are straining healthcare systems and costing lives.In the US, the first quarter (Q1) of 2024 saw a staggering 323 drug shortages, the highest number recorded since the American Society of Health-System Pharmacists (ASHP) began tracking such data in 2001. However, Q2 2024 saw active drug shortages reduce to 300 drugs.While the shortages span a wide range of medications, five categories have been severely impacted in the US — central nervous system drugs, antimicrobials, hormone agents, injectable fluids and electrolytes, and chemotherapy drugs. Other critical medications in short supply include drugs to treat attention deficit hyperactivity disorder (ADHD).View Our Interactive Dashboard on Drug Shortages So Far in 2024 (Free Excel Available)Chemo scarcities spark concerns; vaccine shortage hampers mpox response in AfricaIn the US, shortage of at least 21 chemotherapy drugs has impacted cancer treatments. A survey undertaken by the National Comprehensive Cancer Network found 89 percent of participating centers reporting shortages of at least one critical systemic anticancer therapy. These included drugs like vinblastine, etoposide and topotecan. Since early 2023, supply issues have led to what’s now known as the “carboplatin shortage”, a key platinum-based chemo drug that is impacting cancer treatment. Carboplatin is crucial for treating various cancers, including ovarian, lung, and breast cancer.The good news is that there has been a reduction in shortages of platinum-based chemo drugs such as carboplatin and cisplatin. In fact, the FDA website now mentions the shortage of cisplatin as resolved. However, the shortage of carboplatin persists.Meanwhile, Africa is facing an acute shortage of diagnostic kits, treatments and vaccines to fight the outbreak of monkeypox (mpox). The Africa Centers for Disease Control and Prevention estimates it would need 10 million vaccines to stop the outbreak. Bavarian Nordic’s Jynneos is currently the only widely approved mpox vaccine, and countries like the US, Spain, France and Germany have pledged doses of Jynneos to help Africa fight the outbreak.View Our Interactive Dashboard on Drug Shortages So Far in 2024 (Free Excel Available) Drug shortages impacts ADHD patients in US; Canada implements tiered systemThe US Food and Drug Administration (FDA) first reported a shortage of Adderall, a common ADHD treatment, in October 2022. Since then, the shortage has spread to other crucial medications like Ritalin, Vyvanse, and Focalin. This is a significant issue for the roughly 10 million adults and six million children in the US who rely on such drugs to manage their ADHD symptoms.An already concerning shortage of ADHD medications in the US has the potential to worsen due to some recent events. The Centers for Disease Control and Prevention (CDC) issued a health advisory in June, warning that the arrest of two telehealth executives from Done Global, a digital health company, could exacerbate the ADHD medication shortage. Done Global was accused of illegally distributing Adderall online. The arrests could disrupt care not only for Done Global patients but also for those who use other telehealth services.Meanwhile, Canada has implemented a tiered system for addressing drug shortages, with tier 3 shortages being those with the greatest potential impact on the country’s drug supply and healthcare system. Currently, there are 20 drugs listed under tier 3.View Our Interactive Dashboard on Drug Shortages So Far in 2024 (Free Excel Available) GLP-1 drug shortages create US$ 1 bn shadow industry; Lilly, Novo expand capacitiesThe shortage of glucagon-like peptide-1 (GLP-1) receptor agonists, such as Ozempic, Saxenda, Trulicity, Victoza, Mounjaro, and Zepbound, has been grabbing headlines. These drugs are used in the treatment of diabetes and in weight management.The shortage of these drugs has led to a surge in demand for compounded versions of these medications, creating both opportunities and significant risks. While the FDA’s Food, Drug, and Cosmetic Act allows it to turn a blind eye to pharmacists producing and selling non-approved compounded versions under certain circumstances, this practice has led to a billion-dollar shadow industry of compounded GLP-1 drugs.Eli Lilly has discovered compounded drugs advertised as tirzepatide (Mounjaro and Zepbound) with significant safety, sterility, and efficacy issues. In response to the safety risks, Lilly has taken legal action against several wellness centers, medical spas, and other sellers in the US.To address the supply issues, Lilly has announced its largest manufacturing investment yet, investing an additional US$ 5.3 billion at its Indiana site. Similarly, Novo Nordisk’s parent company is acquiring Catalent for US$ 16.5 billion to increase Wegovy production. Novo is also investing US$ 4.1 billion to develop a new manufacturing facility in Clayton, North Carolina (US).The FDA website continues to list Novo and Lilly’s GLP-1 drugs as “Currently in Shortage”, even though the drugmakers say otherwise. The EMA website says the shortage of Novo’s Wegovy has been resolved but Lilly’s Trulicity and Novo’s Saxenda continue to be in shortage.View Our Interactive Dashboard on Drug Shortages So Far in 2024 (Free Excel Available) FDA works closely with cancer drugmakers; France introduces roadmap to address drug shortagesApart from pharma companies, health authorities and governments are also taking steps to reduce drug shortages. FDA is working closely with five cancer drug manufacturers to increase production capacities. It has also facilitated the re-entry of a previously discontinued cisplatin product into the market.On the legislative front, the US Senate Finance Committee has proposed a draft of a policy that would incentivize generic drug manufacturers to prioritize production of essential medications. These incentives include minimum three-year contracts with stable pricing, contingency contracts with alternate manufacturers, transparency in quality control issues, and modifications to the Medicaid Drug Rebate Program. France, like most European nations, is also facing shortages of medicines like insulin and anti-cancer drugs. But most problematic are its shortages of antibiotics, paracetamol and corticoids. The French government has introduced a new three-year "roadmap" (from 2024 to 2027) to address these shortages. A significant step in this direction is the planned opening of the first European paracetamol factory in Toulouse in 2025, which will help reduce Europe’s dependence on China, India, and the US for this widely used medication.View Our Interactive Dashboard on Drug Shortages So Far in 2024 (Free Excel Available) Our viewThe global drug shortages underscore the fragility of pharmaceutical supply chains and the urgent need for reform. Longstanding drug shortages, particularly those affecting cancer treatments, antibiotics, and essential medications often stem from the low profitability of generic drugs.While investments in manufacturing capacity and regulatory measures are steps in the right direction, a more comprehensive, concerted global approach is needed to resolve the deep-seated systemic issues in the pharmaceutical industry.  

Impressions: 5634

https://www.pharmacompass.com/radio-compass-blog/us-drug-shortages-hit-record-high-in-q1-2024-impacts-cancer-adhd-drugs-lilly-novo-ramp-up-production

#PharmaFlow by PHARMACOMPASS
29 Aug 2024

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

US Medicaid Prescriptions

read-more
read-more

01

arrow
International Sweetener Colloquium
Not Confirmed
arrow
International Sweetener Colloquium
Not Confirmed

Company : App/Fresenius K

Vinblastine Sulfate

Drug Cost (USD) : 2,754

Year : 2023

Prescribers : 11

Prescriptions : 27

blank

02

arrow
International Sweetener Colloquium
Not Confirmed
arrow
International Sweetener Colloquium
Not Confirmed

Company : App/Fresenius K

Vinblastine Sulfate

Drug Cost (USD) : 4,018

Year : 2022

Prescribers : 16

Prescriptions : 42

blank

03

arrow
International Sweetener Colloquium
Not Confirmed
arrow
International Sweetener Colloquium
Not Confirmed

Company : App/Fresenius K

Vinblastine Sulfate

Drug Cost (USD) : 4,648

Year : 2021

Prescribers : 15

Prescriptions : 39

blank

04

arrow
International Sweetener Colloquium
Not Confirmed
arrow
International Sweetener Colloquium
Not Confirmed

Company : App/Fresenius K

Vinblastine Sulfate

Drug Cost (USD) : 3,980

Year : 2020

Prescribers : 11

Prescriptions : 39

blank

05

arrow
International Sweetener Colloquium
Not Confirmed
arrow
International Sweetener Colloquium
Not Confirmed

Company : App/Fresenius K

Vinblastine Sulfate

Drug Cost (USD) : 4,520

Year : 2019

Prescribers : 16

Prescriptions : 55

blank

06

arrow
International Sweetener Colloquium
Not Confirmed
arrow
International Sweetener Colloquium
Not Confirmed

Company : App/Fresenius K

Vinblastine Sulfate

Drug Cost (USD) : 4,361

Year : 2018

Prescribers : 13

Prescriptions : 46

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Regulatory FDF Prices

read-more
read-more

01

Brand Name : Vinblastine

Israel
arrow
International Sweetener Colloquium
Not Confirmed

Brand Name : Vinblastine

Israel
arrow
International Sweetener Colloquium
Not Confirmed

Vinblastine Sulfate

Dosage Form : Vinblastine 10Mg 10Ml 1 Units Pa...

Dosage Strength : 1 vial EV 10 mg 10 ml 1 mg/ml

Price Per Pack (Euro) : 10.07

Published in :

Country : Italy

RX/OTC/DISCN : Class H

blank

02

Brand Name : Velbe

Country
arrow
International Sweetener Colloquium
Not Confirmed

Brand Name : Velbe

Country
arrow
International Sweetener Colloquium
Not Confirmed

Vinblastine Sulfate

Dosage Form : Vinblastine 10Mg 1 Unit Parenter...

Dosage Strength : 1 ampoule EV 10 mg Groun

Price Per Pack (Euro) : 17.9

Published in :

Country : Italy

RX/OTC/DISCN : Class H

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Market Place

Do you need sourcing support? Ask us

FDF DOSSIERS

read-more
read-more
True Fix Pvt. Ltd., an innovative sourcing and distribution company is searching for suppliers of following products for registration and distribution in Brunei Darussalam: 61. Letrozole 2.5mg (Femara) Tablet 50 Units 62. Lomustine 40mg (CCNU) Capsule 50 Units 63. Megestrol Acetate 160mg (Megaplex 160) Tablet 50 Units 64. Mesna 400mg/4mL Injection 50 Units 65. Methotrexate 1000mg Injection 100 Units 66. Methotrexate 50mg/2mL Injection 100 Units 67. Mitomycin 10mg Injection 50 Units 68. Mitomycin 2mg Injection 50 Units 69. Mitotane 500mg (Lysodren) Tablet 50 Units 70. Mitoxantrone 20mg/10mL Injection 50 Units 71. Oxaliplatin 100mg Injection 100 Units 72. Paclitaxel 100mg (Abraxane) Injection 100 Units 73. Paclitaxel 150mg Injection 100 Units 74. Paclitaxel 300mg Injection 100 Units 75. Pazopanib 200mg (Votrient) Tablet 100 Units 76. Pazopanib 400mg (Votrient) Tablet 100 Units 77. Pegfilgrastim 6mg/0.6mL Injection 100 Units 78. Pemetrexed 500mg (Alimta) Injection 100 Units 79. Procarbazine 50mg Capsule 50 Units 80. Regorafenib 40mg (Stivarga) Tablet 50 Units 81. Rituximab 500mg/50mL Injection 100 Units 82. Sorafenib 200mg (Nexavar) Tablet 100 Units 83. Sunitinib 12.5mg (Sutent) Capsule (Hard) 50 Units 84. Tamoxifen 20mg 30's Tablet 100 Units 85. Temozolomide 100mg (Temodal) Capsule 50 Units 86. Trabectedin 1mg (Yondelis) Injection 50 Units 87. Trastuzumab 440mg Injection 100 Units 88. Vinblastine 10mg/10mL Injection 100 Units 89. Vincristine 2mg/2mL Injection 100 Units 90. Vinorelbine 50mg/5mL Injection 50 Units 91. Zoledronic Acid 800mcg/mL 5mL (Zometa) Injection 100 Units Interested suppliers should contact Rizuan Ajik via Email: rizuan@truefixpharma.com or Tel: +673 7246880.
09 Aug 2017

Reply

09 Aug 2017

Reply text-arrow

Reply Comment (1)

09 Aug 2017

Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

EDQM

read-more
read-more

01

EDQM, Council of Europe

Vinblastine sulfate

arrow
International Sweetener Colloquium
Not Confirmed

01

International Sweetener Colloquium
Not Confirmed

Vinblastine sulfate

CAS Number : 143-67-9

Quantity Per Vial : 5 mg

Sale Unit : 1

Order Code : V0300000

Batch No : 4

Price (€) : 79

Storage : -80°C ± 10°C

blank

02

EDQM, Council of Europe

Vinblastine sulfate - reference spectrum

arrow
International Sweetener Colloquium
Not Confirmed

02

International Sweetener Colloquium
Not Confirmed

Vinblastine sulfate - reference spectrum

CAS Number : n/a

Quantity Per Vial : n/a

Sale Unit : 1

Order Code : V0305000

Batch No : 1

Price (€) : 79

Storage :

blank

03

EDQM, Council of Europe

Vincristine sulfate

arrow
International Sweetener Colloquium
Not Confirmed

03

International Sweetener Colloquium
Not Confirmed

Vincristine sulfate

CAS Number : 2068-78-2

Quantity Per Vial : 4.96 mg

Sale Unit : 1

Order Code : V0400000

Batch No : 5

Price (€) : 79

Storage : -80°C ± 10°C

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Looking for 143-67-9 / Vinblastine Sulfate API manufacturers, exporters & distributors?

Vinblastine Sulfate manufacturers, exporters & distributors 1

44

PharmaCompass offers a list of Vinblastine Sulfate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Vinblastine Sulfate manufacturer or Vinblastine Sulfate supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Vinblastine Sulfate manufacturer or Vinblastine Sulfate supplier.

PharmaCompass also assists you with knowing the Vinblastine Sulfate API Price utilized in the formulation of products. Vinblastine Sulfate API Price is not always fixed or binding as the Vinblastine Sulfate Price is obtained through a variety of data sources. The Vinblastine Sulfate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Vinblastine Sulfate

Synonyms

143-67-9, Velban, Velsar, Vinblastine (sulfate), Velbe, Exal

Cas Number

143-67-9

Unique Ingredient Identifier (UNII)

N00W22YO2B

About Vinblastine Sulfate

Antitumor alkaloid isolated from Vinca rosea. (Merck, 11th ed.)

Vinblastine Sulfate Manufacturers

A Vinblastine Sulfate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Vinblastine Sulfate, including repackagers and relabelers. The FDA regulates Vinblastine Sulfate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Vinblastine Sulfate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Vinblastine Sulfate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Vinblastine Sulfate Suppliers

A Vinblastine Sulfate supplier is an individual or a company that provides Vinblastine Sulfate active pharmaceutical ingredient (API) or Vinblastine Sulfate finished formulations upon request. The Vinblastine Sulfate suppliers may include Vinblastine Sulfate API manufacturers, exporters, distributors and traders.

click here to find a list of Vinblastine Sulfate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Vinblastine Sulfate USDMF

A Vinblastine Sulfate DMF (Drug Master File) is a document detailing the whole manufacturing process of Vinblastine Sulfate active pharmaceutical ingredient (API) in detail. Different forms of Vinblastine Sulfate DMFs exist exist since differing nations have different regulations, such as Vinblastine Sulfate USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Vinblastine Sulfate DMF submitted to regulatory agencies in the US is known as a USDMF. Vinblastine Sulfate USDMF includes data on Vinblastine Sulfate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Vinblastine Sulfate USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Vinblastine Sulfate suppliers with USDMF on PharmaCompass.

Vinblastine Sulfate JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Vinblastine Sulfate Drug Master File in Japan (Vinblastine Sulfate JDMF) empowers Vinblastine Sulfate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Vinblastine Sulfate JDMF during the approval evaluation for pharmaceutical products. At the time of Vinblastine Sulfate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Vinblastine Sulfate suppliers with JDMF on PharmaCompass.

Vinblastine Sulfate CEP

A Vinblastine Sulfate CEP of the European Pharmacopoeia monograph is often referred to as a Vinblastine Sulfate Certificate of Suitability (COS). The purpose of a Vinblastine Sulfate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Vinblastine Sulfate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Vinblastine Sulfate to their clients by showing that a Vinblastine Sulfate CEP has been issued for it. The manufacturer submits a Vinblastine Sulfate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Vinblastine Sulfate CEP holder for the record. Additionally, the data presented in the Vinblastine Sulfate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Vinblastine Sulfate DMF.

A Vinblastine Sulfate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Vinblastine Sulfate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of Vinblastine Sulfate suppliers with CEP (COS) on PharmaCompass.

Vinblastine Sulfate WC

A Vinblastine Sulfate written confirmation (Vinblastine Sulfate WC) is an official document issued by a regulatory agency to a Vinblastine Sulfate manufacturer, verifying that the manufacturing facility of a Vinblastine Sulfate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Vinblastine Sulfate APIs or Vinblastine Sulfate finished pharmaceutical products to another nation, regulatory agencies frequently require a Vinblastine Sulfate WC (written confirmation) as part of the regulatory process.

click here to find a list of Vinblastine Sulfate suppliers with Written Confirmation (WC) on PharmaCompass.

Vinblastine Sulfate NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Vinblastine Sulfate as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Vinblastine Sulfate API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Vinblastine Sulfate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Vinblastine Sulfate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Vinblastine Sulfate NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Vinblastine Sulfate suppliers with NDC on PharmaCompass.

Vinblastine Sulfate GMP

Vinblastine Sulfate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Vinblastine Sulfate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Vinblastine Sulfate GMP manufacturer or Vinblastine Sulfate GMP API supplier for your needs.

Vinblastine Sulfate CoA

A Vinblastine Sulfate CoA (Certificate of Analysis) is a formal document that attests to Vinblastine Sulfate's compliance with Vinblastine Sulfate specifications and serves as a tool for batch-level quality control.

Vinblastine Sulfate CoA mostly includes findings from lab analyses of a specific batch. For each Vinblastine Sulfate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Vinblastine Sulfate may be tested according to a variety of international standards, such as European Pharmacopoeia (Vinblastine Sulfate EP), Vinblastine Sulfate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Vinblastine Sulfate USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty